Company / Inventory
Bionano Genomics, Inc. Inventory History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$7.8M
FY2025
5-year range
$7.8M / $29.8M
FY2021-FY2025
Trend
-41.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has declined for 3 consecutive years, from $30M in FY2022 to $8M in FY2025.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +18.7%.
Declined from $28M to $8M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -35.9%
- 5-Year CAGR
- +18.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Bionano Genomics, Inc.'s inventory has declined for 3 consecutive years.
- 5-year CAGR of +18.7%, indicating consistent growth.
- In FY2025, inventory decreased 41.0% year-over-year.
- Peak inventory was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.8M | -41.0% |
| FY2024 | $13.3M | -51.9% |
| FY2023 | $27.6M | -7.3% |
| FY2022 | $29.8M | +140.3% |
| FY2021 | $12.4M | +273.7% |
| FY2020 | $3.3M | -3.7% |
| FY2019 | $3.4M | +222.3% |
| FY2018 | $1.1M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026